Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Hansen Ree

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Plos One|May 16, 2013
Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancerKathrine Røe, Åse Bratland, Ljiljana Vlatkovic, et al.
Plos One|January 23, 2018
Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N. meningitidisUnni Gopinathan, Kathrine Røe Redalen, Anne-Marie Trøseid, et al.
Journal of Extracellular Vesicles|February 8, 2019
An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancerTonje Bjørnetrø, Kathrine Røe Redalen, Sebastian Meltzer, et al.
Frontiers in Microbiology|June 24, 2026
Assessment of 16S rRNA sequencing for analysis of circulating microbial DNA in colorectal cancer patients-proof of concept and early changes during experimental chemoimmunotherapyAdriana M Sanabria, Tonje Bjørnetrø, Anniken J Fuglestad, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survivalKine Mari Bakke, Knut Håkon Hole, Svein Dueland, et al.
Communications Medicine|April 27, 2025
Serum metabolite levels identify incipient metastatic progression of rectal cancerKine M Bakke, Paula A Bousquet, Sebastian Meltzer, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 18, 2013
[Cardioprotective treatment during adjuvant cancer therapy]Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
JACC. Cardiooncology|March 21, 2024
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac DysfunctionAlbulena Mecinaj, Geeta Gulati, Anne Hansen Ree, et al.
European Radiology|June 10, 2026
MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomesAida Kapic Lunder, Sebastian Meltzer, Elin Agathe Frøyen, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2020
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancerSimer J Bains, Hanna Abrahamsson, Kjersti Flatmark, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Plos One|May 16, 2013
Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancerKathrine Røe, Åse Bratland, Ljiljana Vlatkovic, et al.
Plos One|January 23, 2018
Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N. meningitidisUnni Gopinathan, Kathrine Røe Redalen, Anne-Marie Trøseid, et al.
Journal of Extracellular Vesicles|February 8, 2019
An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancerTonje Bjørnetrø, Kathrine Røe Redalen, Sebastian Meltzer, et al.
Frontiers in Microbiology|June 24, 2026
Assessment of 16S rRNA sequencing for analysis of circulating microbial DNA in colorectal cancer patients-proof of concept and early changes during experimental chemoimmunotherapyAdriana M Sanabria, Tonje Bjørnetrø, Anniken J Fuglestad, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survivalKine Mari Bakke, Knut Håkon Hole, Svein Dueland, et al.
Communications Medicine|April 27, 2025
Serum metabolite levels identify incipient metastatic progression of rectal cancerKine M Bakke, Paula A Bousquet, Sebastian Meltzer, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 18, 2013
[Cardioprotective treatment during adjuvant cancer therapy]Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
JACC. Cardiooncology|March 21, 2024
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac DysfunctionAlbulena Mecinaj, Geeta Gulati, Anne Hansen Ree, et al.
European Radiology|June 10, 2026
MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomesAida Kapic Lunder, Sebastian Meltzer, Elin Agathe Frøyen, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2020
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancerSimer J Bains, Hanna Abrahamsson, Kjersti Flatmark, et al.
Pageof 11